Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etamsylate vs Placebo for Bleeding Prevention in HSCT Recipients
NCT07442513Phase 3Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Dec 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etamsylate in hemorrhage, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Started Dec 2025; status: recruiting.
02
Drugs
etamsylate
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT07442513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07442513.